Hyperparathyroidism in patients with primary aldosteronism: Cross-sectional and interventional data from the GECOH study

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 1, 2012, Pages

  Pilz, Stefan ^a,b   Kienreich, Katharina ^a   Drechsler, Christiane ^c   Ritz, Eberhard ^d   Fahrleitner Pammer, Astrid ^a   Gaksch, Martin ^a   Meinitzer, Andreas ^a   März, Winfried ^a,e,f   Pieber, Thomas R ^a   Tomaschitz, Andreas ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e SYNLAB ACADEMY   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CREATININE; EPLERENONE; PARATHYROID HORMONE; SPIRONOLACTONE;

ADULT; ARTICLE; AUSTRIA; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CALCIUM URINE LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERPARATHYROIDISM; HYPERTENSION; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; TERTIARY HEALTH CARE; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM;

ADULT; AGED; ALDOSTERONE; BLOOD PRESSURE; CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERALDOSTERONISM; HYPERPARATHYROIDISM; HYPERTENSION; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENIN-ANGIOTENSIN SYSTEM;

EID: 84855509623     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2183     Document Type: Article

References (21)

1. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-1248
2. Vidal A, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, Weber KT 2006 Calcium paradox of aldosteronism and the role of the parathyroid glands. Am J Physiol Heart Circ Physiol 290:H286-H294
3. Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, Smith RA, Gerling IC, Weber KT 2005 Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 111:871-878
4. Suki WN, Schwettmann RS, Rector Jr FC, Seldin DW 1968 Effect of chronic mineralocorticoid administration on calcium excretion in the rat. Am J Physiol 215:71-74
5. Pilz S, Tomaschitz A, März W, Cavalier E, Ritz E 2010 Aldosterone and parathyroid hormone: a complex and clinically relevant relationship. Calcif Tissue Int 87:373-374
6. Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J 2009 Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119:2765-2771
7. Pilz S, Tomaschitz A, Drechsler C, Ritz E, Boehm BO, Grammer TB, März W 2010 Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 31:1591-1598
8. Brunaud L, Germain A, Zarnegar R, Rancier M, Alrasheedi S, Caillard C, Ayav A, Weryha G, Mirallie E, Bresler L 2009 Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. Surgery 146:1035-1041
9. Resnick LM, Laragh JH 1985 Calcium metabolism and parathyroid function in primary aldosteronism. Am J Med 78:385-390
10. Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C 1995 Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am J Hypertens 8:884-893
11. Barkan A, Marilus R, Winkelsberg G, Yeshurun D, Blum I 1980 Primary hyperparathyroidism: possible cause of primary hyperaldosteronism in a 60-year-old woman. J Clin Endocrinol Metab 51:144-147
12. Pilz S, Tomaschitz A, Stepan V, Obermayer-Pietsch B, Fahrleitner-Pammer A, Schweighofer N, Portugaller HR, Sourij H, Dobnig H, Meinitzer A, Pieber TR 2009 Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism. BMC Endocr Disord 9:11
13. Runyan AL, Chhokar VS, Sun Y, Bhattacharya SK, Runyan JW, Weber KT 2005 Bone loss in rats with aldosteronism. Am J Med Sci 330:1-7
14. Law PH, Sun Y, Bhattacharya SK, Chhokar VS, Weber KT 2005 Diuretics and bone loss in rats with aldosteronism. J Am Coll Cardiol 46:142-146
15. Khouzam RN, Dishmon DA, Farah V, Flax SD, Carbone LD, Weber KT 2006 Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure. Am J Med Sci 331:30-34
16. Carbone LD, Cross JD, Raza SH, Bush AJ, Sepanski RJ, Dhawan S, Khan BQ, Gupta M, Ahmad K, Khouzam RN, Dishmon DA, Nesheiwat JP, Hajjar MA, Chishti WA, Nasser W, Khan M, Womack CR, Cho T, Haskin AR, Weber KT 2008 Fracture risk in men with congestive heart failure risk reduction with spironolactone. J Am Coll Cardiol 52:135-138
17. Montoli A, Colussi G, Minetti L 1992 Hypercalcaemia in Addison's disease: calciotropic hormone profile and bone histology. J Intern Med 232:535-540
18. Bernini G, Moretti A, Lonzi S, Bendinelli C, Miccoli P, Salvetti A 1999 Renin-angiotensin-aldosterone system in primary hyperparathyroidism before and after surgery. Metabolism 48:298-300
19. Kovács L, Góth MI, Szabolcs I, Dohán O, Ferencz A, Szilá gyi G 1998 The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism. Eur J Endocrinol 138:543-547
20. Gennari C, Nami R, Gonnelli S 1995 Hypertension and primary hyperparathyroidism: the role of adrenergic and renin-angiotensin-aldosterone systems. Miner Electrolyte Metab 21:77-81
21. Olgaard K, Lewin E, Bro S, Daugaard H, Egfjord M, Pless V 1994 Enhancement of the stimulatory effect of calcium on aldosterone secretion by parathyroid hormone. Miner Electrolyte Metab 20:309-314